These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 18089497)
1. Review of the cytologic features of noninvasive ductal carcinomas of the pancreas: differences from invasive ductal carcinoma. Hara H; Suda K Am J Clin Pathol; 2008 Jan; 129(1):115-29. PubMed ID: 18089497 [TBL] [Abstract][Full Text] [Related]
2. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327 [TBL] [Abstract][Full Text] [Related]
3. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756 [TBL] [Abstract][Full Text] [Related]
4. Cytologic study of noninvasive intraductal papillary-mucinous carcinoma of the pancreas. Hara H; Suda K; Oyama T Acta Cytol; 2002; 46(3):519-26. PubMed ID: 12040647 [TBL] [Abstract][Full Text] [Related]
6. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT). Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444 [TBL] [Abstract][Full Text] [Related]
7. Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation. Hayashi A; Aishima S; Miyasaka Y; Nakata K; Morimatsu K; Oda Y; Nagai E; Oda Y; Tanaka M; Tsuneyoshi M Hum Pathol; 2010 Nov; 41(11):1507-15. PubMed ID: 20656320 [TBL] [Abstract][Full Text] [Related]
8. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Ban S; Naitoh Y; Mino-Kenudson M; Sakurai T; Kuroda M; Koyama I; Lauwers GY; Shimizu M Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512 [TBL] [Abstract][Full Text] [Related]
9. Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach. Katabi N; Klimstra DS J Clin Pathol; 2008 Dec; 61(12):1303-13. PubMed ID: 18703569 [TBL] [Abstract][Full Text] [Related]
10. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN. Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063 [TBL] [Abstract][Full Text] [Related]
11. Is the intraductal papillary mucinous neoplasia of the biliary tract a counterpart of pancreatic papillary mucinous neoplasm? Klöppel G; Kosmahl M J Hepatol; 2006 Feb; 44(2):249-50. PubMed ID: 16360969 [No Abstract] [Full Text] [Related]
12. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas. Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281 [TBL] [Abstract][Full Text] [Related]
13. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas. Tsukahara M; Nagai H; Kamiakito T; Kawata H; Takayashiki N; Saito K; Tanaka A Pathol Int; 2005 Feb; 55(2):63-9. PubMed ID: 15693851 [TBL] [Abstract][Full Text] [Related]
14. Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas. Sanada Y; Kunita S; Yoshida K Oncol Rep; 2008 Jun; 19(6):1435-43. PubMed ID: 18497948 [TBL] [Abstract][Full Text] [Related]
15. Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas. Kashima K; Ohike N; Mukai S; Sato M; Takahashi M; Morohoshi T Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):86-90. PubMed ID: 18234645 [TBL] [Abstract][Full Text] [Related]
16. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm. Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920 [TBL] [Abstract][Full Text] [Related]
18. Molecular genetics of intraductal papillary-mucinous neoplasms of the pancreas. Furukawa T J Hepatobiliary Pancreat Surg; 2007; 14(3):233-7. PubMed ID: 17520197 [TBL] [Abstract][Full Text] [Related]
19. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression. Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T; Shimamoto F; Hiyama E J Surg Oncol; 2008 Apr; 97(5):469-75. PubMed ID: 18161862 [TBL] [Abstract][Full Text] [Related]
20. Different patterns of p16INK4A and p53 protein expressions in intraductal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia. Abe K; Suda K; Arakawa A; Yamasaki S; Sonoue H; Mitani K; Nobukawa B Pancreas; 2007 Jan; 34(1):85-91. PubMed ID: 17198188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]